Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Karin Fisch
Introduction
Karin Fisch is a notable inventor based in Cologne, Germany. She has made significant contributions to the field of oncology, particularly in the development of methods that enhance chemotherapy regimens for breast cancer patients. Her innovative approach has the potential to improve treatment outcomes for individuals facing recurrent neoplastic diseases.
Latest Patents
Karin Fisch holds a patent for a method that predicts the benefit of including taxane in chemotherapy regimens for patients with breast cancer. This patent outlines a process that involves determining the expression levels of the marker genes S100P and PCSK6. By mathematically combining these expression level values, a combined score is generated. This score is then compared to a reference value, where a high score indicates a potential benefit from taxane inclusion, while a low score suggests otherwise.
Career Highlights
Karin Fisch is associated with Sividon Diagnostics GmbH, where she applies her expertise in developing innovative diagnostic methods. Her work is instrumental in advancing personalized medicine, particularly in the context of breast cancer treatment.
Collaborations
Karin collaborates with esteemed colleagues such as Jan Brase and Ralf Kronenwett. Their combined efforts contribute to the ongoing research and development in the field of cancer diagnostics.
Conclusion
Karin Fisch's contributions to cancer treatment through her innovative patent demonstrate her commitment to improving patient outcomes. Her work exemplifies the vital role of inventors in advancing medical science and enhancing therapeutic strategies.